Core Viewpoint - The article highlights the growing importance of nuclear medicine and radiopharmaceuticals in the healthcare industry, emphasizing the unique advantages of nuclear drugs in precision medicine and the anticipated growth of the market in China, projected to reach 26 billion RMB by 2030 [1]. Summary by Sections Nuclear Drug Market Overview - Nuclear drugs, which are radioactive pharmaceuticals, play a crucial role in diagnosing cardiovascular diseases, neurodegenerative diseases, and treating malignant tumors [1]. - The Chinese market for radiopharmaceuticals is expected to reach 26 billion RMB by 2030, indicating significant growth potential [1]. Current Industry Challenges - The majority of radiopharmaceuticals available in China are generic versions of foreign products that have been on the market for many years, leading to severe homogenization and a lack of innovative, competitive drugs [1]. - The current state of nuclear drug research and development, along with future trends, is a key focus for the industry, with new technologies and methods emerging as critical areas for exploration and application [1]. Upcoming Event - An online seminar titled "Innovative Technologies and Methods in Nuclear Drug Development" is scheduled for July 24, 2025, organized by Instrument Information Network, featuring expert presentations on various topics related to nuclear drug innovation [2]. - The agenda includes discussions on nuclear drug innovation, radioactive isotope detection instruments, and advancements in molecular imaging equipment [2].